(Q38044928)

English

Nodular lymphocyte predominant Hodgkin lymphoma in children and adolescents--a comprehensive review of biology, clinical course and treatment options.

scientific article published on 21 September 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22994199%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Nodular lymphocyte predominant Hodgkin lymphoma in children and adolescents--a comprehensive review of biology, clinical course and treatment options (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22994199%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

1 reference

based on heuristic

inferred from title

Hodgkin lymphoma

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22994199%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

author name string

Stephen Daw

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22994199%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

language of work or name

0 references

publication date

21 September 2012

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22994199%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

British Journal of Haematology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22994199%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

159

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22994199%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22994199%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

288-298

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22994199%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Transformation to aggressive lymphoma in nodular lymphocyte-predominant Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1111%2FBJH.12055

21 January 2018

Cytokine gene expression profile distinguishes CD4+/CD57+ T cells of the nodular lymphocyte predominance type of Hodgkin's lymphoma from their tonsillar counterparts

1 reference

https://api.crossref.org/works/10.1111%2FBJH.12055

21 January 2018

Autologous hematopoietic stem-cell transplantation for relapsed or refractory Hodgkin's disease in children and adolescents.

1 reference

https://api.crossref.org/works/10.1111%2FBJH.12055

21 January 2018

Nodular, lymphocyte-predominant Hodgkin lymphoma: a long-term study and analysis of transformation to diffuse large B-cell lymphoma in a cohort of 164 patients from the Adult Lymphoma Study Group

1 reference

https://api.crossref.org/works/10.1111%2FBJH.12055

21 January 2018

Clinical presentation and outcome in lymphocyte-predominant Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1111%2FBJH.12055

21 January 2018

Nodular lymphocyte-predominant Hodgkin lymphoma with nodules resembling T-cell/histiocyte-rich B-cell lymphoma: differential diagnosis between nodular lymphocyte-predominant Hodgkin lymphoma and T-cell/histiocyte-rich B-cell lymphoma

1 reference

https://api.crossref.org/works/10.1111%2FBJH.12055

21 January 2018

Origin and pathogenesis of nodular lymphocyte-predominant Hodgkin lymphoma as revealed by global gene expression analysis

1 reference

https://api.crossref.org/works/10.1111%2FBJH.12055

21 January 2018

[Nodular lymphocyte predominance Hodgkin's disease and its differential diagnosis].

1 reference

https://api.crossref.org/works/10.1111%2FBJH.12055

21 January 2018

Early-stage, lymphocyte-predominant Hodgkin's lymphoma: patient outcomes from a large, single-institution series with long follow-up.

1 reference

https://api.crossref.org/works/10.1111%2FBJH.12055

21 January 2018

Clinical presentation and outcomes of lymphocyte-predominant Hodgkin disease at the University of Florida

1 reference

https://api.crossref.org/works/10.1111%2FBJH.12055

21 January 2018

Anti-CD20 monoclonal antibody (rituximab) for therapy of CD20-positive nodular lymphocyte-predominant Hodgkin lymphoma in an 10-year-old girl.

1 reference

https://api.crossref.org/works/10.1111%2FBJH.12055

21 January 2018

Clinical presentation, course, and prognostic factors in lymphocyte-predominant Hodgkin's disease and lymphocyte-rich classical Hodgkin's disease: report from the European Task Force on Lymphoma Project on Lymphocyte-Predominant Hodgkin's Disease

1 reference

https://api.crossref.org/works/10.1111%2FBJH.12055

21 January 2018

Final results of a prospective clinical trial with VAMP and low-dose involved-field radiation for children with low-risk Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1111%2FBJH.12055

21 January 2018

Lymphocyte predominant Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1111%2FBJH.12055

21 January 2018

The molecular pathogenesis of Hodgkin lymphoma.

1 reference

https://api.crossref.org/works/10.1111%2FBJH.12055

21 January 2018

Outcome of children with nodular lymphocyte predominant Hodgkin lymphoma - a Children's Cancer and Leukaemia Group report.

1 reference

https://api.crossref.org/works/10.1111%2FBJH.12055

21 January 2018

The unique entity of nodular lymphocyte-predominant Hodgkin lymphoma: current approaches to diagnosis and management

1 reference

https://api.crossref.org/works/10.1111%2FBJH.12055

21 January 2018

Lymphocyte-predominant Hodgkin lymphoma--clinical features and treatment outcomes from a 30-year experience

1 reference

https://api.crossref.org/works/10.1111%2FBJH.12055

21 January 2018

The biology of Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1111%2FBJH.12055

21 January 2018

Pathogenetic importance and therapeutic implications of NF-κB in lymphoid malignancies

1 reference

https://api.crossref.org/works/10.1111%2FBJH.12055

21 January 2018

Resection alone in 58 children with limited stage, lymphocyte-predominant Hodgkin lymphoma-experience from the European network group on pediatric Hodgkin lymphoma

1 reference

https://api.crossref.org/works/10.1111%2FBJH.12055

21 January 2018

Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001

1 reference

https://api.crossref.org/works/10.1111%2FBJH.12055

21 January 2018

Results of little or no treatment for lymphocyte-predominant Hodgkin disease in children and adolescents

1 reference

https://api.crossref.org/works/10.1111%2FBJH.12055

21 January 2018

Randomized comparison of low-dose involved-field radiotherapy and no radiotherapy for children with Hodgkin's disease who achieve a complete response to chemotherapy

1 reference

https://api.crossref.org/works/10.1111%2FBJH.12055

21 January 2018

Expression of the human germinal center-associated lymphoma (HGAL) protein, a new marker of germinal center B-cell derivation

1 reference

https://api.crossref.org/works/10.1111%2FBJH.12055

21 January 2018

Extended field radiotherapy, combined modality treatment or involved field radiotherapy for patients with stage IA lymphocyte-predominant Hodgkin's lymphoma: a retrospective analysis from the German Hodgkin Study Group (GHSG).

1 reference

https://api.crossref.org/works/10.1111%2FBJH.12055

21 January 2018

Lymphocyte-predominant and classical Hodgkin's lymphoma: a comprehensive analysis from the German Hodgkin Study Group

1 reference

https://api.crossref.org/works/10.1111%2FBJH.12055

21 January 2018

Peripheral blood lymphocyte/monocyte ratio at diagnosis and survival in nodular lymphocyte-predominant Hodgkin lymphoma.

1 reference

https://api.crossref.org/works/10.1111%2FBJH.12055

21 January 2018

IgD positive L&H cells identify a unique subset of nodular lymphocyte predominant Hodgkin lymphoma.

1 reference

https://api.crossref.org/works/10.1111%2FBJH.12055

21 January 2018

Hodgkin lymphoma across the age spectrum: epidemiology, therapy, and late effects

1 reference

https://api.crossref.org/works/10.1111%2FBJH.12055

21 January 2018

Quantitative diffusion weighted MRI: a functional biomarker of nodal disease in Hodgkin lymphoma?

1 reference

https://api.crossref.org/works/10.1111%2FBJH.12055

21 January 2018

Molecular cytogenetic analyses of immunoglobulin loci in nodular lymphocyte predominant Hodgkin's lymphoma reveal a recurrent IGH-BCL6 juxtaposition

1 reference

https://api.crossref.org/works/10.1111%2FBJH.12055

21 January 2018

Lymphocyte-predominant Hodgkin disease in children

1 reference

https://api.crossref.org/works/10.1111%2FBJH.12055

21 January 2018

Radiotherapy alone for lymphocyte-predominant Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1111%2FBJH.12055

21 January 2018

Pathogenesis of classical and lymphocyte-predominant Hodgkin lymphoma

1 reference

https://api.crossref.org/works/10.1111%2FBJH.12055

21 January 2018

Rituximab in relapsed lymphocyte-predominant Hodgkin lymphoma: long-term results of a phase 2 trial by the German Hodgkin Lymphoma Study Group (GHSG).

1 reference

https://api.crossref.org/works/10.1111%2FBJH.12055

21 January 2018

Notch is an essential upstream regulator of NF-κB and is relevant for survival of Hodgkin and Reed-Sternberg cells

1 reference

https://api.crossref.org/works/10.1111%2FBJH.12055

21 January 2018

Role of FDG PET in the management of childhood lymphomas--case proven or is the jury still out?

1 reference

https://api.crossref.org/works/10.1111%2FBJH.12055

21 January 2018

Nodular lymphocyte-predominant hodgkin lymphoma with atypical T cells: a morphologic variant mimicking peripheral T-cell lymphoma.

1 reference

https://api.crossref.org/works/10.1111%2FBJH.12055

21 January 2018

European Organization for Research and Treatment of Cancer and Groupe d'Etude des Lymphomes de l'Adulte very favorable and favorable, lymphocyte-predominant Hodgkin disease.

1 reference

https://api.crossref.org/works/10.1111%2FBJH.12055

21 January 2018

Treatment outcome after low intensity chemotherapy [CVP] in children and adolescents with early stage nodular lymphocyte predominant Hodgkin’s lymphoma – An Anglo-French collaborative report

1 reference

https://api.crossref.org/works/10.1111%2FBJH.12055

21 January 2018

Outcome After Autologous Hemopoietic Stem Cell Transplantation in Relapsed or Refractory Childhood Hodgkin Disease

1 reference

https://api.crossref.org/works/10.1111%2FBJH.12055

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38044928&oldid=2146175810"